Published in Mod Pathol on November 01, 2002
One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch (2008) 1.75
Optical coherence tomography: the intraoperative assessment of lymph nodes in breast cancer. IEEE Eng Med Biol Mag (2010) 1.03
Metastatic breast cancer cells in lymph nodes increase nodal collagen density. Sci Rep (2015) 0.84
Radiotherapy and breast reconstruction: oncology, cosmesis and complications. Gland Surg (2012) 0.81
Factors associated with the misdiagnosis of sentinel lymph nodes using touch imprint cytology for early stage breast cancer. Oncol Lett (2011) 0.79
The evaluation and optimization of intraoperative touch imprint cytology for sentinel lymph nodes in early-stage breast cancer in China. World J Surg (2010) 0.76
The value of intraoperative frozen section examination of sentinel lymph nodes in surgical management of breast carcinoma. Langenbecks Arch Surg (2009) 0.75
Investigation of optical coherence micro-elastography as a method to visualize micro-architecture in human axillary lymph nodes. BMC Cancer (2016) 0.75
Intraoperative Frozen Section Evaluation of Sentinel Lymph Nodes in Breast Carcinoma: Single-Institution Indian Experience. Indian J Surg (2013) 0.75
[Minutes of the working group on gynecopathology and breast pathology. On the occasion of the 92nd Annual Congress of the German Society for Pathology in Berlin]. Pathologe (2008) 0.75
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol (2007) 7.73
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol (2012) 5.06
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol (2009) 3.04
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase. ChemMedChem (2007) 2.96
Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol (2006) 2.82
Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol (2007) 2.46
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol (2004) 2.30
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg (2007) 2.28
Vulvar seborrheic keratosis: is there a relationship to human papillomavirus? J Low Genit Tract Dis (2014) 2.14
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. J Clin Oncol (2013) 2.12
Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery (2006) 2.09
Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol (2006) 2.06
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study. J Thorac Oncol (2014) 2.04
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid (2005) 1.89
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg (2007) 1.85
Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol (2003) 1.81
High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J (2006) 1.76
Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? J Clin Oncol (2010) 1.69
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol (2005) 1.69
Use of a new method in reaching consensus on the cause of cytologic-histologic correlation discrepancy. Am J Clin Pathol (2006) 1.68
Prevention of surgical site infections in high-risk patients with laparotomy incisions using negative-pressure therapy. Am J Surg (2013) 1.68
Restorative yoga for women with breast cancer: findings from a randomized pilot study. Psychooncology (2009) 1.65
Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis (2008) 1.64
Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy? Ann Surg Oncol (2011) 1.62
Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg (2006) 1.59
Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. Arch Surg (2011) 1.57
Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery (2008) 1.49
E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature. Am J Clin Pathol (2004) 1.46
Safe introduction of a new surgical technique: remote telementoring for posterior retroperitoneoscopic adrenalectomy. ANZ J Surg (2012) 1.45
Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes. AJR Am J Roentgenol (2003) 1.45
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg (2003) 1.45
Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol (2005) 1.44
Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery (2011) 1.43
Soft tissue amyloidoma of the extremities: a case report and review of the literature. Arch Pathol Lab Med (2004) 1.43
Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics. Cancer Invest (2012) 1.42
Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb perfusion. Am Surg (2007) 1.40
Tubercular scrotal disease. Acta Cytol (2006) 1.39
Carcinoid tumors of the duodenum. Surgery (2005) 1.37
Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology (2012) 1.36
Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics (2002) 1.34
Leiomyosarcoma of the inferior vena cava: surgical management and clinical results. Am Surg (2005) 1.31
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol (2006) 1.31
Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery (2005) 1.26
Staging and current treatment of hepatocellular carcinoma. Radiographics (2005) 1.23
Acceleration of Integra incorporation in complex tissue defects with subatmospheric pressure. Plast Reconstr Surg (2004) 1.22
Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol (2010) 1.22
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg (2004) 1.22
Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol (2009) 1.21
DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.20
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene (2002) 1.20
Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene (2003) 1.20
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale. Curr Probl Cancer (2009) 1.19
Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol (2013) 1.19
Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol (2005) 1.16
Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery (2010) 1.15
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab (2008) 1.14
Primary hyperparathyroidism. Oncologist (2007) 1.14
A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer (2011) 1.14
Intraoperative evaluation of lumpectomy margins by imprint cytology with histologic correlation: a community hospital experience. Arch Pathol Lab Med (2002) 1.12
Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol (2007) 1.10
The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? J Am Coll Surg (2013) 1.09
Recent advances in thyroid cancer. Curr Probl Surg (2008) 1.09
CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo. Mol Cancer Ther (2006) 1.09
Multiple endocrine neoplasia syndromes. Surg Clin North Am (2008) 1.09
Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy. Breast Cancer Res Treat (2006) 1.08
Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol (2007) 1.08
Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res (2008) 1.08
Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol (2008) 1.06
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy. Am J Clin Pathol (2002) 1.05
Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg (2008) 1.05
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol (2011) 1.05
A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*. Cancer (2010) 1.05
Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review. Am J Clin Pathol (2007) 1.04
Adenocarcinoma of the appendix is rarely detected by colonoscopy. J Gastrointest Surg (2008) 1.03
Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg (2010) 1.03
Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg (2006) 1.03
Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg (2005) 1.02
Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid (2004) 1.02